Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 2
1953 1
1954 4
1998 1
2001 1
2002 3
2003 1
2004 1
2005 1
2006 2
2007 1
2008 1
2009 2
2010 2
2011 5
2012 2
2013 2
2014 1
2015 6
2016 2
2017 6
2018 2
2019 7
2020 6
2021 6
2022 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Drugging the 'undruggable' cancer targets.
Dang CV, Reddy EP, Shokat KM, Soucek L. Dang CV, et al. Among authors: soucek l. Nat Rev Cancer. 2017 Aug;17(8):502-508. doi: 10.1038/nrc.2017.36. Epub 2017 Jun 23. Nat Rev Cancer. 2017. PMID: 28643779 Free PMC article. Review.
Tamoxifen administration to mice.
Whitfield J, Littlewood T, Soucek L. Whitfield J, et al. Among authors: soucek l. Cold Spring Harb Protoc. 2015 Mar 2;2015(3):269-71. doi: 10.1101/pdb.prot077966. Cold Spring Harb Protoc. 2015. PMID: 25734062 Free PMC article.
Finding MYCure.
Beaulieu ME, Soucek L. Beaulieu ME, et al. Among authors: soucek l. Mol Cell Oncol. 2019 Jun 20;6(5):e1618178. doi: 10.1080/23723556.2019.1618178. eCollection 2019. Mol Cell Oncol. 2019. PMID: 31528695 Free PMC article.
Editorial overview: Peptides in cancer.
Whitfield J, Soucek L. Whitfield J, et al. Among authors: soucek l. Curr Opin Pharmacol. 2019 Aug;47:iii-v. doi: 10.1016/j.coph.2019.06.001. Epub 2019 Jun 28. Curr Opin Pharmacol. 2019. PMID: 31257021 Free PMC article. No abstract available.
MYC inhibitors in multiple myeloma.
Martínez-Martín S, Soucek L. Martínez-Martín S, et al. Among authors: soucek l. Cancer Drug Resist. 2021 Aug 13;4(4):842-865. doi: 10.20517/cdr.2021.55. eCollection 2021. Cancer Drug Resist. 2021. PMID: 35582389 Free PMC article. Review.
Targeting MYC-driven lymphoma: lessons learned and future directions.
Martínez-Martín S, Beaulieu ME, Soucek L. Martínez-Martín S, et al. Among authors: soucek l. Cancer Drug Resist. 2023 Apr 12;6(2):205-222. doi: 10.20517/cdr.2022.127. eCollection 2023. Cancer Drug Resist. 2023. PMID: 37457123 Free PMC article. Review.
Tumor microenvironment: becoming sick of Myc.
Whitfield JR, Soucek L. Whitfield JR, et al. Among authors: soucek l. Cell Mol Life Sci. 2012 Mar;69(6):931-4. doi: 10.1007/s00018-011-0860-x. Epub 2011 Oct 28. Cell Mol Life Sci. 2012. PMID: 22033838 Free PMC article. Review.
Live or Die: Choice Mechanisms in Stressed Cells.
Cecconi F, Soucek L, Taub DD, Ziparo E. Cecconi F, et al. Among authors: soucek l. Mediators Inflamm. 2015;2015:454863. doi: 10.1155/2015/454863. Epub 2015 Oct 8. Mediators Inflamm. 2015. PMID: 26508817 Free PMC article. No abstract available.
An "-omycs" Toolbox to Work with MYC.
Whitfield J, Soucek L. Whitfield J, et al. Among authors: soucek l. Methods Mol Biol. 2021;2318:1-11. doi: 10.1007/978-1-0716-1476-1_1. Methods Mol Biol. 2021. PMID: 34019283
The long journey to bring a Myc inhibitor to the clinic.
Whitfield JR, Soucek L. Whitfield JR, et al. Among authors: soucek l. J Cell Biol. 2021 Aug 2;220(8):e202103090. doi: 10.1083/jcb.202103090. Epub 2021 Jun 23. J Cell Biol. 2021. PMID: 34160558 Free PMC article. Review.
72 results